MTOR and acute respiratory distress syndrome: Unlike the traditional forms, Anti-PD-L1 (Programmed death ligand 1), a promising measure in treating ALI/ARDS, promotes autophagy by inhibiting the PI3K/Akt/mTOR pathway at the ER in neutrophils, thus attenuating inflammatory responses (47).